BlueSprig, one of the nation’s leading providers of Applied Behavior Analysis therapy for children, announced today that Will Abbott has been appointed as Chief Executive Officer. Abbott will help guide BlueSprig through continued expansion and growth and support the company’s core mission of changing the world for children with autism.
Abbott joins BlueSprig from InnovaCare, a leader in integrated and value-based health care services, where he served as Chief Executive Officer. He brings deep expertise leading scaled multi-site organizations with an understanding of how best to support practitioners in the field. Among other roles in the health care industry, Abbott previously spent more than a decade at CVS Caremark, where he led the national operations team and its long-term care division.
“BlueSprig is at the forefront of delivering outstanding care to its patients and invests significantly in research to advance ABA practices,” said Abbott. “I am thrilled to be joining BlueSprig at this exciting time in the company’s growth and look forward to working alongside the talented BlueSprig team to support our mission of providing the highest-quality care for children with autism.”
“We are delighted to welcome Will to BlueSprig and are confident that his extensive experience in the health care sector, particularly with large, multi-site organizations such as ours, will be instrumental in supporting our clinicians and teams in the field,” said Ali Satvat, Chair of BlueSprig’s Board of Directors. “We look forward to the continued success and growth of BlueSprig and superior delivery of care under Will’s leadership.”
About BlueSprig
BlueSprig, founded in 2017, is a leading provider of Applied Behavior Analysis (ABA) treatment services to children with autism spectrum disorder (ASD). BlueSprig is committed to providing compassionate, individualized, and evidence-based behavior analysis treatment. Headquartered in Houston, TX, BlueSprig is a nationwide provider of ABA treatment with 160+ locations. For additional information about BlueSprig or to receive updates, visit www.bluesprigautism.com.
